Keyphrases
High-risk Human Papillomavirus (HR-HPV)
75%
Genital Warts
75%
Postherpetic Neuralgia
66%
Omalizumab
50%
Herpes Zoster
50%
Capsaicin
50%
Clinical Diagnosis
50%
Denmark
40%
Severity Index
38%
Area Index
38%
Human Papillomavirus Vaccine
37%
Warts
37%
Low Prevalence
33%
Vaccination
31%
Capsaicin Patch
30%
Systematic Literature Review
28%
Extragenital
28%
Sexually Transmitted Infections
27%
Secukinumab
25%
Novel Scoring System
25%
BD ProbeTec ET
25%
In-house PCR
25%
PorA
25%
Dupilumab
25%
Atopic Dermatitis
25%
Retrospective multicenter Study
25%
Haemophilus Ducreyi
25%
Local Transmission
25%
Laser Evaporation
25%
Cervical Dysplasia
25%
Rosaceae
25%
Prurigo Nodularis
25%
Moderate-to-severe Psoriasis
25%
Notalgia Paresthetica
25%
Topical Patch
25%
Disease Burden
25%
Chronic Urticaria
25%
Clinical Assessment
25%
Pediatric
25%
Quality of Life Impact
25%
Patient Impact
25%
Clinical Treatment
25%
Young Girls
25%
Kidney Transplant Recipients
25%
In(III)
25%
Excision
25%
Syphilis
25%
Pain Relief
25%
Transplantation
25%
Chronic Pruritus
25%
Medicine and Dentistry
Wart Virus
100%
Genital Wart
85%
Prevalence
66%
Disseminated Herpes Zoster
50%
Postherpetic Neuralgia
37%
Verruca Vulgaris
33%
Polymerase Chain Reaction
33%
Pseudogene
25%
Rhinophyma
25%
Dupilumab
25%
Uterine Cervix Dysplasia
25%
Scoring System
25%
Quality of Life
25%
Haemophilus ducreyi
25%
Prurigo nodularis
25%
Clinical Assessment
25%
Disease Burden
25%
Syphilis
25%
Pediatrics
25%
Ulcer
25%
Carbon Dioxide
25%
Polymerase Chain Reaction
25%
Toxic Epidermal Necrolysis
25%
Gonorrhea
25%
Infliximab
25%
Acne Fulminans
25%
Opiate
16%
Anticonvulsant
16%
Symptom
16%
Clinical Study
14%
Disease
13%
Base
12%
Chancroid
12%
Bacterial DNA
12%
Exudate
12%
Oropharyngeal Cancer
12%
Dry Eye
11%
Penile Cancer
10%
Anal Cancer
10%
Chlamydia Trachomatis
8%
Neisseria gonorrhoeae
8%
Acute Disease
8%
Postinflammatory Hyperpigmentation
8%
Herpes Zoster Pain
8%
Tricyclic Antidepressant
8%
Mycoplasma Pneumonia
8%
Persistent Pain
8%
False Positive Result
8%
Dermatome
8%
Single Drug Dose
8%
Pharmacology, Toxicology and Pharmaceutical Science
Postherpetic Neuralgia
56%
Omalizumab
50%
Capsaicin
50%
Vaccination Policy
50%
Herpes Zoster
50%
Chronic Urticaria
28%
Atopic Dermatitis
28%
Human Papillomavirus
25%
Secukinumab
25%
Neurodermatitis
25%
Dupilumab
25%
Pruritus
25%
Psoriasis Vulgaris
25%
Condyloma acuminatum
25%
Acne Fulminans
25%
Psoriasis
13%
Opiate
12%
Anticonvulsive Agent
12%
Side Effect
11%
Symptom
9%
Disease
9%
Placebo
9%
Randomized Controlled Trial
7%
Fc Receptor
7%
Monoclonal Antibody
7%
Varicella Zoster Vaccine
6%
Vesicular Rash
6%
Acute Disease
6%
Rash
6%
Clinical Study
6%
Immunoglobulin
6%
Antiviral Therapy
6%
Tricyclic Antidepressant
6%
Adverse Event
5%
Transient Receptor Potential Channel
5%
Lidocaine Plus Prilocaine
5%
Allodynia
5%
Tramadol
5%
